Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer

NCT00536614 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

GENETIC: cetuximab

Sponsor

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Collaborators

[object Object]